{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Noblesville",
      "state": "IN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72177",
      "recalling_firm": "Pharmakon Pharmaceuticals",
      "address_1": "14450 Getz Rd",
      "address_2": "N/A",
      "postal_code": "46060-3303",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0604-2016",
      "product_description": "Lidocaine HCI (PF) Inj, USP 2%, injectable packed in syringes, Total dosage 100 mg/ 5mL, Rx only, PHARMAKON Pharmaceuticals, Inc.",
      "product_quantity": "400",
      "reason_for_recall": "Stability data does not support expiry.",
      "recall_initiation_date": "20150819",
      "center_classification_date": "20160127",
      "termination_date": "20170509",
      "report_date": "20160203",
      "code_info": "All lots with expiration dates up to 11/17/2015"
    }
  ]
}